Related Experiment Video
Updated: Jun 4, 2025
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
10.7K
Microglial Mayhem NLRP3 Inflammasome's Role in Multiple Sclerosis Pathology
Hua Fan1, Qizhi Fu2, Ganqin Du3
1Office of Research & Innovation, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
CNS Neuroscience & Therapeutics
|December 18, 2024
Summary
The NLRP3 inflammasome plays a key role in multiple sclerosis (MS) by driving inflammation in microglia/macrophages, which damages neurons. Targeting this inflammasome may offer new therapeutic strategies for MS.
Area of Science:
- Neuroimmunology
- Inflammasome Biology
- Neurodegenerative Diseases
Background:
- Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease with an unclear etiology.
- The immune system plays a critical role in MS progression.
- NLRP3 inflammasomes are increasingly implicated in autoimmune diseases.
Purpose of the Study:
- To explore the role of NLR inflammasomes, specifically NLRP3, in the pathogenesis of multiple sclerosis (MS).
- To elucidate the activation mechanism of NLRP3 inflammasomes in microglia/macrophages (MG/MФ) and their contribution to neuronal damage in MS.
Main Methods:
- Comprehensive review of existing literature and research findings.
- Analysis of NLRP3 inflammasome activation pathways in MG/MФ relevant to MS.
Main Results:
- NLR inflammasomes, particularly NLRP3, are pivotal in MS pathogenesis.
- Activated MG/MФ orchestrate an inflammatory response that perpetuates neuronal damage in MS.
Conclusions:
- NLRP3 inflammasomes significantly contribute to MS pathogenesis through activation in MG/MФ.
- Understanding NLRP3 inflammasome activation provides insights into MS mechanisms.
- Targeting NLRP3 inflammasomes presents a potential therapeutic avenue for MS treatment.
Related Concept Videos
01:24T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K